Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print June 11, 2003.
Biol Reprod 2003, 10.1095/biolreprod.103.015610
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/4/1294    most recent
biolreprod.103.015610v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Sairam, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.
Right arrow Articles by Sairam, M. R.
Agricola
Right arrow Articles by Yang, Y.
Right arrow Articles by Sairam, M. R.
BIOLOGY OF REPRODUCTION 69, 1294–1302 (2003)
DOI: 10.1095/biolreprod.103.015610
© 2003 by the Society for the Study of Reproduction, Inc.


Ovary

Developmental and Molecular Aberrations Associated with Deterioration of Oogenesis During Complete or Partial Follicle-Stimulating Hormone Receptor Deficiency in Mice1

Yinzhi Yang3,4, Agneta Balla3,5, Natalia Danilovich3, and M. Ram Sairam2,3,4,5

Molecular Reproduction Research Laboratory,3 Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7 Faculté de Médecine,4 Université de Montréal, Montréal, Quebec, Canada H3C 3J7 Department of Physiology,5 McGill University, Montreal, Quebec, Canada H3G 1Y6


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Targeted disruption of the mouse FSH receptor gene (FSH-R) that mediates the action of the FSH results in a gene dose-related ovarian phenotype in the developing as well as the adult animal. While null females (FORKO) are sterile, the haplo-insufficient mice experience early reproductive senescence. The purpose of this study was to first record changes in oocyte development in the null FORKO and haplo-insufficient mice. Oocyte growth is significantly retarded in the null mutants with thinner zona pellucida in preantral follicles, but thicker zona pellucida in secondary follicles. This morphometric change indicates developmental aberrations in coordination of the germ cell (oocyte) and the somatic granulosa cell (GC) compartments. Markers for primordial germ cell proliferation and oocyte growth, such as the c-Kit/Kit-ligand and bone morphogenetic protein-15 (BMP-15) were downregulated in both null and +/- ovaries, suggesting disrupted communication between oocyte and GCs. Extensive changes in the expression of other oocyte-specific gene products like the zona pellucida glycoproteins (zona pellucida A, B, and C) indicate major alteration in the extracellular matrix surrounding the germ cells. This led to leaky germ cells that allowed infiltration of somatic cells. These results show that the loss of FSH-R signaling alters the follicular environment, where oocyte-granulosa interactions are perturbed, creating an out-of-phase germ cell and somatic cell development. We believe that these data provide an experimental paradigm to explore the mechanisms responsible for preserving the structural integrity and quality of oocytes at different ages.

cumulus cells, follicle-stimulating hormone receptor, granulosa cells, oocyte development, ovary


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Folliculogenesis is a continuous developmental process wherein the oocytes grow steadily as the surrounding somatic layers of granulosa cells (GCs) proliferate and differentiate and subsequently other layers of theca cells develop outside the follicle at defined stages of ovarian development [1, 2]. The ultimate goal of folliculogenesis is to produce a mature egg for ovulation and fertilization. Each mammalian ovary has a fixed number of primordial follicles at birth that later develop to primary, secondary, and preantral/antral follicles. For example, the newborn mouse has about 15 000 oocytes that, within 2 days, complete the first meiotic division and stay arrested until puberty. At puberty, under the cyclic influence of pituitary gonadotropins, signaling cascades are triggered, stimulating follicular growth, oocyte maturation, including release from meiotic arrest and ovulation. Only those follicles that enter this route are rescued, while a majority of preantral/antral follicles undergo a degenerative process called atresia through apoptotic elimination. Besides external endocrine signals, local paracrine and autocrine mechanisms within the follicular environment interact to determine optimal oocyte and GC development and polarization. This is accomplished by two-way intercellular communication that includes factors secreted by both the oocyte and GCs that act on the juxtaposed cells [2]. Among the gene products recently characterized to play a significant role in this interaction are the c-Kit/Kit-ligand system [3], factor in the germ line alpha (FIG{alpha}) [4, 5], growth differentiation factor 9 (GDF-9) [6, 7], and bone morphogenetic protein 15 (BMP-15) [810].

The Kit-ligand expressed by GCs of growing follicles interacts with c-Kit, a tyrosine kinase receptor of the platelet-derived growth factor receptor family, produced by the oocytes and theca cells [3]. Kit-ligand together with c-Kit controls oocyte growth and theca cell differentiation and protects preantral follicles from apoptosis [11, 12]. FIG{alpha} is a germ cell-specific basic helix-loop-helix transcription factor that has been implicated in coordinate expression of three zona pellucida (ZP) glycoproteins [4]. Consequently, mice that lack FIG{alpha} are infertile because they fail to produce the three ZP transcripts [5]. GDF 9 [13, 14] and BMP-15 (also called GDF 9b) are members of the transforming growth factor-ß (TGFß) superfamily selectively expressed in the oocytes. Both these proteins induce GC proliferation and differentiation and are necessary for female fertility [6, 13]. BMP-15 has two functions: the inhibition of FSH-induced GC cytodifferentiation through the inhibition of FSH receptor (FSH-R) expression in GCs and stimulation of GC proliferation [9]. BMP-15 and Kit-ligand are all expressed in the early stages of follicular development and appear to be involved in GC mitosis [10].

The mouse ZP comprising three glycoproteins called ZP-1 (ZP-B), ZP-2 (ZP-A), and ZP-3 (ZP-C) is an extracellular matrix that surrounds the growing oocytes and remains associated with it after ovulation and formation of the early embryo [15]. Despite the fact that the zona matrix physically separates the oocyte and the surrounding somatic GCs, very close associations are continuously maintained throughout folliculogenesis by means of gap junctions that [16] allow interaction of paracrine factors noted above.

The major endocrine signal that is essential for normal folliculogenesis is FSH [17] that acts by binding to its receptor expressed exclusively on GCs. More recent reports, however, indicate its presence in oocytes, suggesting additional sites of action in the ovary [18, 19]. FSH interacts with its receptor isoforms, resulting in activation of a variety of signaling pathways to initiate follicle development and induce steroidogenesis [20, 21]. Targeted disruption of the mouse FSH-R gene [22] results in female sterility and induces a gene dose-related novel ovarian phenotype in the adult animal [23]. FSH-R gene disruption causes complete loss of ovarian estrogen production, creating steroid hormone imbalance [2325]. The mutant females exhibit profound changes in ovarian structure and secondary sex-organ deficiencies. They are sterile because of a block in folliculogenesis before antral follicle formation. Interestingly, heterozygous female mice also undergo early ovarian senescence and lose fertility [24]. In consideration of such a phenotype, this haplo-insufficient animal has been dubbed the "Menopause mouse" [26]. The hormonal imbalances and other changes following loss of FSH-R signaling lead to follicular degeneration in both null and +/- mice.

The development of follicles in the mammalian ovary involves a bidirectional communication system between the follicular cells and oocyte [16]. Our preceding article established the perinatal developmental changes in the somatic cells of the follicle and noted that structural alterations in the ovary of null females are apparent at or before 2 days of life [27]. In the present investigation, our aim was to characterize the developmental state of the oocytes during FSH-R deficiency and explore follicle relationship with known oocyte-specific gene products. Because poor oocyte quality is a major cause for the aging-related decline in fertility in middle-aged women [28] and increase in the incidence of aneuploidy [29], we have taken advantage of the strong impact of receptor haplo-insufficiency in inducing early reproductive senescence to examine some oocyte characteristics in this model. Our data reveals that FSH-R deletion produces major changes in oocyte structure (and function), disrupting intercellular communication in the follicle, creating opportunities for additional mechanistic investigations.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

All experiments involving animals were performed according to institutionally approved and animal care guidelines. Mice were housed five mice per cage under standard and approved laboratory conditions with 12L:12D at 22°C, with unrestricted access to food and water. Mice were genotyped by polymerase chain reaction from DNA extracted from tailpieces or toes. For all experiments in this study, virgin 24-day-old and 3- and 7-mo-old female mice were used. All animals were killed at random, disregarding the stage of the estrous cycle with the exception that sections used for histology and immunohistochemistry from +/- and +/- are derived from mice killed on the morning of proestrus. In any case, this was not relevant for the 1-mo-old mice or the FORKO (any age) that do not cycle.

Antibodies

The following antibodies were used in our study to perform either immunohistochemistry or Western blot analysis. Well-characterized and specific ZP-A (ZP2), ZP-B (ZP1), and ZP-C (ZP3) antibodies were kindly donated by Dr. U. Eberspaecher (Schering AG Berlin, Germany) [30]. These investigators prepared the ZP-A rabbit antibody against synthetic peptides CGTRYKFEDDKVVVYE and NRDDPNIKLVLDDC that had no homology to ZP-B or ZP-C. Rabbit antisera against the latter two were prepared using highly purified recombinant proteins. It should be noted that the nomenclature of ZP glycoproteins has been changed [31] to reflect the proteins according to their length rather than apparent molecular weights. The old nomenclatures are indicated in parentheses for clarification. The BMP-15 antibody was the gift of Dr. S. Shimasaki (University of California, San Diego). Antibodies to c-Kit and Kit-ligand were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).

Histological Analysis of Follicles

Ovaries were removed and cleaned of fat and fixed in 10% buffered formalin for 24 h at 4°C, processed in a tissue processor for paraffin embedding. Then 5-µm sections were cut serially and stained by standard protocols with hematoxylin and eosin. Histological examination of the ovaries was performed by light microscopy and microphotographs were taken at the same time using a Carl Zeiss microscope (Jena, Germany).

Follicle Development and Zona Pellucida Thickness

Follicles were classified into six groups as described in the previous article [27]. In brief, a primordial is a follicle with an intact oocyte surrounded by a single layer of flattened GCs. Primary follicles consist of an intact enlarged oocyte and are surrounded by a single layer of mixed squamous and cuboidal or a single layer of cuboidal GCs, secondary is a small preantral follicle with two layers of GCs. A preantral follicle has more than two layers of GCs. An antral structure is a follicle with a fluid-filled antrum. A preovulatory follicle is one that is close to the stage of ovulation. As will be noted in the results, FORKO mice lack structures beyond the preantral stage.

The follicle development at different ages was analyzed by measuring the diameter of oocytes using a microscope coupled to a camera. More than 1500 follicles were examined to compile data on oocytes. There were 4–5 mice for each age and genotype and more than 20–80 follicles of each type were included in each case. Only those follicles sectioned through the oocyte nucleolus (the largest follicle cross-section) were analyzed. The longest and shortest follicular and oocyte diameter were recorded and their average was used [24]. The zona pellucida thickness was measured in four directions around the oocyte of each follicle. Data are plotted as mean oocyte, ZP, and follicle diameters ± SEM.

Immunohistochemistry

Mouse ovary sections (5 µm) were deparaffinized, rehydrated using an immunoCruz kit (Santa Cruz Biotechnology Inc.), incubated in peroxidase block solution in order to quench endogenous peroxidase activity. To avoid any nonspecific reactivity of the antibodies, the sections were pretreated with 3% normal rabbit serum for 1 h and incubated with primary antisera (antibodies ZP-A 1:400, ZP-B 1:250, ZP-C 1:1000, c-Kit 1:50, BMP-15 1:3000 in normal rabbit serum) overnight at 4°C. The sections were washed three times for 5 min each with PBS before the biotinylated secondary antibody (goat anti-rabbit 1:1000 in serum) was added for 1 h at room temperature. This was followed by incubation with horseradish peroxidase (HRP)-conjugated antibody. After a final wash in PBS, the immunoreactive sites were visualized with the peroxidase substrate 3,3'-diaminobenzidine tetrahydrochloride dihydrate. The sections were counterstained with hematoxylin and mounted with Permount (Fisher Scientific Company (Fairlawn, NJ). Finally, slides were observed under a microscope and pictures were taken at the same time using a Carl Zeiss microscope and computer-aided Eclipse image analyzer (Northern Eclipse, Ontario, Canada). In these evaluations, sections processed by treating with normal serum instead of the primary antibody served as the negative control.

Western Blotting

Ovaries were homogenized in a lysis buffer (50 mM Tris-HCl, pH 6.8) with additives described previously [23]. Samples (60–100 µg protein) were diluted with equal volume of reducing loading buffer (187 mmol/L Tris, pH 6.8; 2% SDS; 2% ß-mercaptoethanol; 1% sucrose; 0.01% bromophenol blue) and boiled for 6 min. Proteins were separated by SDS-polyacrylamide gel electrophoresis on a 6%–10% acrylamide gel in parallel with prestained protein molecular weight markers (BioRad, Richmond, CA) and blotted onto polyvinylidene difluoride (PVDF) membranes (Amersham Pharmacia, Buckinghamshire, U.K.) overnight using wet blot apparatus (Biorad). Membranes were then blocked for 2 h at room temperature in 0.02 mol/L TBS (pH 7.6) containing 5% weight/volume dry milk powder, and then washed in TBS with 0.1% Tween-20 (TBST) before being incubated for 1–2 h with primary antibody (anti-c-Kit ligand goat polyclonal, 1: 750, Santa Cruz) in TBST with 5% dry milk or the ZP-A antibody (1:2500) as appropriate. Bound antibody was detected using a rabbit anti-goat (1:6000) or goat anti-rabbit (1:15 000) HRP linked secondary antibody) and the enhanced chemiluminescence visualization system (Amersham Pharmacia Biotech) ECL+ Plus according to the manufacturer's instructions. Quantitative comparisons were done using Image-Quant software (Amersham Biosciences, Uppsala, Sweden).

Statistical Analysis

Data are presented as the mean ± SEM and were analyzed by Student t-test or ANOVA with a Fischer least square difference (LSD) post hoc test using P < 0.05 as the level of significance.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Patterns of Oocyte Growth in FSH-R-Deficient Mice

At the onset of these studies, there was no information on the potential influence of FSH-R signaling per se on oocyte growth and function. Therefore, ovaries from mice of all three genotypes of three different ages (24 days and 3 and 7 mo) were serially sectioned for morphometric analysis. Comparing data on oocyte diameter, we found differences for different types of follicles in the three genotypes (Fig. 1). In the immature +/+ mouse, the oocyte diameter steadily increased from 13 µm in the primordial, reaching about 62 µm in the antral stage. The growth patterns for the +/- were similar to the wild type except at the primary stage, where they were significantly larger. The size of -/- oocytes differed significantly from the wild type (WT) at the primary (showing a decrease) and preantral (increase) stages. It should be noted that there are no antral follicles in the -/- ovary at any age. At 3 mo of age, oocyte size was in general smaller in the FORKO ovary as compared with the wild type at all stages. For the heterozygous mice, significant differences were seen for the secondary and preantral follicles. At this age, the wild-type and +/- oocytes of antral follicles reached an average diameter of 108 µm. At 7 mo, there was no apparent difference among the groups and the maximum diameter in the wild type reached 74 µm in the antral stage, being considerably smaller than that seen at 3 mo.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 1. Developmental influence on oocyte growth at different ages. In each panel, the diameter of oocytes in follicles (20–80) of different sizes for all three genotypes are shown. A) Twenty-four-day-old mice, (B) 3-mo-old mice, and (C) 7-mo-old mice. *, Denotes significant difference (P < 0.05 when compared with +/+). **P <= 0.005

Thickness of Zona Pellucida Matrix

The ZP is first observed as extracellular patches that come together and form a uniform matrix surrounding oocytes in primary follicles. This structure increases in width to about 7 µm surrounding fully grown oocytes of early antral follicles in the mouse [32]. Thus, the thickness of the ZP reflects the local environment during folliculogenesis and serves as an indicator of oocyte development. Accordingly, ZP thickness was measured in all follicle types of 3-mo-old mice (Fig. 2) as the size of oocytes was maximal at this age. This matrix gradually thickens with increasing follicular growth, becoming maximal in the ovulatory follicle (8.3 ± 0.06 µm) in the wild-type ovary. For this genotype, differences were significant at each stage (see Fig. 2, inset). Structural changes were evident in the +/- ovaries at two stages: the zona matrix was thinner in the antral and ovulatory follicles (P < 0.005). In the FORKO mice, the average thickness of the ZP matrix in preantral follicles is smaller (4.57 ± 0.114 µm) than that of wild-type mice (5.43 ± 0.148 µm) (P < 0.001). But in secondary follicles, the ZP became thicker (4.58 ± 0.147 µm) than that of wild type (3.64 ± 0.284 µm) (P < 0.005). This result confirms that, in the FORKO mice, some oocytes developed earlier than surrounding GCs, indicating developmental imbalance (see Fig. 3F). As reported previously [23, 27], antral follicles are absent in FORKO ovaries.



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 2. Zona pellucida development in 3-mo-old mice. The thickness of the zona is considered as an indication of the functional state of the follicle. The compilations are from comparisons of oocytes from the different types of follicles (n = 20–80) in the three genotypes. For designation of follicle type, see Materials and Methods. A preovulatory follicle is one that appears to be in the final stages preparatory to the expulsion of the ovum. Note that the antral and preovulatory follicles are completely absent in null FORKO mice. Asterisks indicate statistically significant difference compared with the WT. *, P < 0.05, **, P < 0.005, ***, P < 0.001. As indicated in the inset, the increase in ZP thickness in the +/+ is significantly different from the previous stage. Growth in the -/- is stagnant



View larger version (99K):
[in this window]
[in a new window]
 
FIG. 3. Patterns of histological change in oocytes of the FSH-R mutant ovaries and examples of early aberrations. The panels assemble examples that are typical of alterations observed in the FSH-R ovaries at the three different ages. Pictures shown are for 3-mo-old ovaries. In the top panel, comparable stage follicles are shown. A) In the +/+ follicle, the oocyte has smooth, rounded, and evenly distributed ZP. B) In the +/- follicle, oocyte shape irregularity starts. C) Oocyte in a FORKO ovary is not round and zona is uneven. Examples of variations are indicated by arrows. D) Ovarian follicles in a +/- ovary having two oocytes (see arrow). Degenerating GCs are also seen in these follicles. E) Example of a -/- oocyte in which the zona appears discontinuous and patchy (arrow), allowing infiltration of loose GCs (asterisks) into the oocyte. This was not found in the +/+ or +/- follicle. F) Example of an oocyte (arrow) big enough to be in preantral follicle but now found in association with only one to three layers of GCs. Bar = 25 µm (AC and E) and bar = 100 µm (D and F)

Histological Characterization of Zona Pellucida, Oocyte, and Follicle Growth in FORKO and Heterozygous Mice

The normal oocyte at various stages of its development in a healthy follicle is a perfectly rounded structure. Usually the ZP is present in the perivitelline space between the plasma membrane of the oocytes and the layer of surrounding GCs. However, during folliculogenesis, we noted that the periphery of the oocyte in FORKO mice was not round and smooth as in the wild type (see Fig. 3, A–C). Some irregularity from its normal shape was found in the ZP of most -/- oocytes at 3 mo. The ZP matrix that appeared uneven in null mutant was also apparent in +/- animals. A random sampling of ovarian sections from different mice revealed that about 5% of follicles contained GCs between the zona pellucida and the oolemma in the FORKO females (Fig. 3E). It may be noted that we have excluded such follicles and oocytes from our estimates of size or thickness (Fig. 2). This feature was unique to the null mutants because it was not seen in the +/- at any age examined. In the previous article [27], we have pointed out that this aberration of infiltration is already evident at 24 days of age in the FORKO ovary. In Figure 3E (see arrow), we depict the appearance of breaks, indicating discontinuity in the extracellular matrix that might allow the seepage of GCs (denoted by asterisks) into the oocyte. In contrast with this aberrant characteristic in null mice, the +/- ovaries showed a different feature: frequent appearance of two oocytes present in one follicle at the secondary or preantral stages. Although this was seen rarely in the control animals, their frequent presence in the +/- animals was unique to this genotype (Fig. 3D) and occurred at all ages (from 24 days to 7 mo) that we have examined. Figure 3F depicts an example of an enlarged oocyte in a secondary follicle in the FORKO ovary.

Expression of Oocyte Markers c-Kit, Kit-ligand, and BMP-15

In order to gain some mechanistic insights into the above perturbations, we evaluated some well-established candidate markers that participate in oocyte-GC communication. In the normal ovary, c-Kit is expressed in the oocyte and Kit-ligand expression is confined to GCs in the ovary [3]. In the 24-day-old mouse ovary, c-Kit was clearly detectable by immunohistochemistry. Clear positive staining was seen in the oocyte of +/+ ovary, but not in the FORKO ovary, where it was barely detectable (Fig. 4C). Ovarian sections from heterozygous mice showed positive staining that was intermediate; it was weaker than that of wild type but stronger than that of FORKO (Fig. 4, B and C). The antisera that were available to us only allowed quantitation by Western blotting of the Kit-ligand in the ovarian extracts. By this analysis, expression in the FORKO ovary was 47% of wild type, and in the heterozygous state, it was 85% of wild type (Fig. 5A). BMP-15 expression in the 24-day ovary of FORKO and heterozygous mice was also weaker than that of wild-type ovary (Fig. 4, D–F).



View larger version (87K):
[in this window]
[in a new window]
 
FIG. 4. Immunohistochemical detection of c-Kit and BMP-15 in the oocyte. The example shown is for a 30-day-old ovary. A) Wild-type ovaries express c-Kit in the oocyte, where a strong reaction is evident. B) Section of a +/- ovary with weaker staining in a preantral follicle. C) Expression in a -/- follicle with very faint signal. DF) BMP-15 localization for the +/+, +/-, and -/-, respectively. Bars = 50 µm (AC and A inset) and bar = 100 µm (DF and D inset)



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 5. Western blotting comparing ovarian protein expression. A) Top panel shows a blot with equal amounts of protein extracts of the 3-mo-old +/+, +/-, and -/- ovaries probed with c-Kit-ligand antibody. ß actin is shown as a control following reprobing of the membrane with its antibody. Bottom panel compares ratios (densitometry) of c-Kit ligand expression normalized to ß actin. B) Blot for ZP glycoprotein ZP-A with densitometric values normalized in the bottom panel. In these experiments, the small size of the -/- ovaries required pooling of six or more ovaries per each experiment (n = 3)

Distribution of Zona Pellucida Proteins (ZP-A, B, C) in the Oocyte

Mouse ZP matrix is composed of three glycoproteins, ZP-A, ZP-B, and ZP-C [15]. These glycoproteins are secreted by the growing mouse oocytes. ZP-A and ZP-C assemble into organized filaments that are cross-linked by ZP-B. The resulting extracellular matrix, called the ZP, is unique to the oocyte and is a thick coat that surrounds oocytes and plays a crucial function in oogenesis, fertilization, and early embryogenesis [32]. In addition, ZP-A and ZP-C are believed to be essential for gamete recognition [33]. Thus, it was of interest to understand if the oocytes in the mutants would exhibit molecular changes that would affect their regulatory function. We were able to use formalin-fixed and paraffin-embedded sections of mouse ovaries to assess ZP protein expression during different ages in the three genotypes. Using the specific antibodies (see Materials and Methods), staining for all three ZP proteins was observed in the ovaries of normal and mutant mice. However, their expression patterns were greatly altered in a differential manner. For ZP-A and C proteins in the +/+, expression was confined to the adjacent extracellular area around the oocyte, with virtually no staining in GCs. However, with anti ZP-B, expression was intense and localized to the whole oocyte but some weakly positive reaction was evident in the GCs. In this case, GCs of mutant ovaries showed more intense staining than normal ovaries. In the 24-day-old FORKO female, the ZP-A (Fig. 6C) and ZP-B (Fig. 6F) expressions were lower. We also noted lower expression for these proteins in haplo-insufficient mice at this early age (Fig. 6, B and E). The pattern of ZP-C expression was also markedly different. In this case, it was stronger in both heterozygous and FORKO mice compared with the wild type (Fig. 6, G–I). Abundant expression in the FORKO ovary is clearly evident when compared with the +/+ or +/- state (compare Fig. 6, I with H). Overall, there was clear evidence for imbalance in the expression of these important glycoproteins that was gene-dosage dependent. We were able to quantify expression by Western blotting only for ZP-A (see Fig. 5B). ZP-A expression in the FORKO ovary was reduced to 49% of the wild type, whereas in the heterozygote, there was a 33% deficit. This confirmed the reduced staining that was seen by immunohistochemistry (Fig. 6, B and C).



View larger version (124K):
[in this window]
[in a new window]
 
FIG. 6. Expression of oocyte zona glycoproteins revealed by immunohistochemistry. All the examples shown are for the 24-day-old ovary of the three genotypes. The insets in each of the left panels show control omitting the primary antibody but including normal serum. A) Expression pattern using antipeptide ZP-A antibody. Protein is detected as a ring around the oocyte. Expression is lower in +/- and -/- ovaries. B) Antibody to recombinant ZP-B. This antibody detects intense reaction in the whole oocyte. C) Antibody to recombinant ZP-C. This antibody detects intense reaction as a rim around the oocyte. Very high expression is evident in oocytes of both the +/- and -/- ovarian sections, with the latter being the strongest. Bar = 100 µm (AC and inset A) and bar = 50 µm (DI and insets D and G)


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Successful mammalian reproduction requires a healthy and competent egg that, upon fertilization, must be adequately protected and nurtured in vivo during gestation. The critical and dramatic changes that occur in this period are in part dictated by the competency of the egg that also determines unsuccessful events such as premature termination or reduced fertility or other developmental abnormalities. Many of these fall under the broad term "miscarriage" that terminates a pregnancy. In mammalian ovaries, the individual follicles consist of an innermost oocyte representing the germ cell, surrounding GCs of the somatic type, and outer layers of thecal cells. The follicles develop through primordial, primary, secondary, and preantral stages before acquiring an antral cavity that is filled with fluid bathing the cumulus cells as well as the oocytes. These developmental sequences are a prerequisite for GC differentiation and ovulation. Under the influence of gonadotropins, a fluid-filled structure called the antrum is formed and the selected antral follicles further increase in size, converting to ovulatory follicles. The preovulatory surge of gonadotropin (luteinizing hormone, LH) stimulates oocyte maturation that results in the release of oocytes from meiotic arrest and allows for GC-cumulus expansion. The fate of the other large preantral follicles that are not selected for ovulation is to undergo atresia [2].

Follicle development depends on optimal communication between oocyte and the surrounding GCs [34, 35]. Such transcellular communication within the follicular compartment occurs as a result of direct physical contacts (intercellular junctions) and the local production of soluble factors that act in an autocrine or paracrine fashion [36]. This communication is bidirectional and occurs throughout follicular development [16, 37, 38]. These events must be tightly coordinated to ensure orderly development and completion of meiosis [34].

Our data of the present study reveals that this bidirectional communication is influenced in a quantitative manner by FSH-R signaling events, and oocyte contribution to this process is greatly perturbed in the ovaries of mutant mice during the peri/postnatal period. Thus, targeted disruption of the FSH-R gene adds critical information to study the role played by receptor signaling in maintaining the follicular milieu in a state conducive for development. The phenomenon of gene haplo-insufficiency in mutant animals derived from homologous recombination is of considerable experimental interest as shown by the present studies because such animals have allowed us to investigate gene-dose-related effects as they appear at different ages (data not shown). Even though the young +/- and -/- mutants were normal in outward appearance, functional deficits were already apparent at 24 days. This emphasizes the need for careful developmental assessments to understand quantitative changes that could become apparent later in life. In the previous communication, we compared the postnatal developmental pattern of the ovary and showed that follicles from FORKO mice are structurally defective [27].

Previous reports from this laboratory on adult FSH-R mutants pointed out differences in follicular growth patterns [23, 24]. Extending this further, we can now hypothesize that some of the molecular alterations detected in the current study might be a direct result of developmental asynchrony between the oocyte and GCs. However, additional investigations such as the transplantation of asynchronous and growth-advanced mutant oocytes into normal early-stage ovaries might help in establishing if their signals alter GC and folliculogenesis.

In addition, several interesting features of the current report with respect to oocyte development merit attention. The incidence of multiple oocyte follicles appeared to be unique to the +/- ovary (Fig. 3D) because they were extremely rare or not present in the +/+ or -/- ovaries. Because this was already apparent in some animals at 1 mo (not shown), we believe that such an abnormality takes effect quite early in development. This type of abnormal follicles has also been noted in ovaries of mutant mice lacking GDF-9 or BMP-15, both of which are oocyte-secreted growth factors [39, 40]. Several other deletions of genes expressed in GCs also exhibit this aberration as in ovaries of mice lacking the Ahch [41], which encodes the transcription factor Dax-1 involved in sex determination, or the Ca2+/Calmodulin-dependent protein kinase IV knockout females that show reduced fertility [42] and in mice that overexpress the inhibin alpha gene [43]. In comparison with all the above null mutants, the aberrations observed in our study are unique in that the multiple oocyte follicles appear only in the haplo-insufficient state. Although the mechanisms underlying such abnormalities are complex, it is possible that early developmental events that lead to follicle organization are aberrant and incomplete in the +/- FSH-R ovaries. Further work would be necessary to unravel the delicate imbalance of factors that prevail in the +/- state.

In contrast with the state in +/- FSH-R mice, the oocytes of null ovaries showed an infiltration of GCs in some preantral stage follicles (Fig. 3E), an event that never occurred in the +/+ ovary at any age (see below). The initial increases in zona thickness, only in secondary follicles but not at other stages of FORKO mice, indicate faster progress and developmental imbalance in the interaction between the oocyte and GC. Since such follicles also appeared in the GDF-9 knockout mice [7], we might speculate a deficit in GDF-9 secretion in the FSH-R-deficient state pending further analysis of this important oocyte-specific gene. However, based on drastic changes in many other markers (see below), we can also suggest that oocyte structure and function is irreversibly altered in the ovaries of our mutants. That some of these impairments occur as early as 24 days [27] indicates the strong impact of early establishment of communication in preserving the structural integrity of the oocyte-GC as a functional unit.

The Kit-ligand is a product of GCs specifically in ovarian follicles, where its expression is hormonally regulated [12]. Its alteration as seen in the whole ovary (Fig. 5A) coupled with drastic curtailment of the c-Kit expression (Fig. 4, A–C), can be taken as evidence of impaired or lack of communication between the adjacent germ cell and somatic compartments. In addition to controlling oocyte growth and theca cell differentiation during early folliculogenesis in the normal state, the c-Kit/Kit-ligand also protects preantral follicles from apoptosis. Moreover, formation of an antral cavity also requires a functional c-Kit/Kit-ligand system [11, 12]. In the FSH-R mutant, the ovarian follicle never advanced to these later developmental stages. Thus, because many steps of follicular development are controlled by the interactions between c-Kit and Kit-ligand, the phenotypes observed in our study could be a direct result of its perturbation.

Drastic changes seen in BMP-15 protein expression in our mutants offer additional proof that oocyte development is impaired. BMP-15, the oocyte-derived factor, is a known physiological regulator of follicle cell proliferation and differentiation necessary for female fertility [8]. BMP-15 mRNA and protein are both coexpressed in oocytes throughout folliculogenesis and GCs are the first targets of BMP-15. Our observations on reduced (in +/- state) or virtual absence of the protein in the -/- ovary (Fig. 4) are consistent with the reported data on BMP-15 regulation of proliferation and differentiation of GCs, inhibition of FSH-R mRNA expression [9], as well as selective modulation of FSH action. This indicates that FSH-R and BMP-15 have a direct relationship at least at the level of translation of the latter.

An unexpected and remarkable oocyte defect noted in the FSH-R mutants is the state of the ZP that is normally formed during follicular development in the ovary. In the normal animal, this thick extracellular coat surrounding the growing oocytes, ovulated eggs, and preimplantation embryos provides for oocyte survival, binding and activation of sperm cells leading to fertilization and early embryogenesis. It also prevents polyspermy [38]. The ZP matrix consisting of three proteins (ZP-A, -B, and -C) physically separates the oocyte and GCs but maintains close associations throughout follicular development via paracrine factors and cellular processes. Several of the changes we have observed in these proteins (Fig. 6) are reminiscent of alterations reported for mouse mutants lacking these individual proteins. For example, in ZP-B-lacking mice, the ZP appears thinner than in normal mice and there is an ectopic accumulation of GCs in the perivitelline space [44], as also seen in FORKO mice (Fig. 3). Mice that lack ZP-A also produce a thin zona matrix but the abnormal zona matrix does not seem to affect the initial stages of folliculogenesis. However, the numbers of antral follicles significantly decrease in these mice [45]. Mice without ZP-C do not form a ZP matrix at all, even early in oogenesis [45]. The overexpression of this protein in both the +/- and -/- FSH-R mice is apparently insufficient to compensate for the loss in the other two because reproductive deficits occur in both states. This indicates that there is a different rate of change of the proteins that make up the ZP matrix in the FSH-R mutants. The FORKO mice develop an uneven ZP surrounding the growing oocyte and some cumulus cells even cross the ZP matrix to cover the oocyte (Fig. 3E). The matrix in the zona is visualized as a structure organized by filaments of heterodimeric repeats of ZP-A and ZP-C cross-linked by ZP-B [30, 46]. Based on this, pathology similar to that seen in our mutants in the ZP-B knockout mice was explained by the fragility and weakness of the ZP due to the mutation [44]. Thus, the ZP becomes leaky in the FSH-R ovary, facilitating the entry of somatic cells that are themselves not organized very compactly. Indeed, visual appearance of breaks in such oocytes in our study (Fig. 3E) confirms that the extracellular matrix is not continuous, creating a dysfunctional assembly that lacks the required filament structure [46]. A more detailed study of these features is likely to reveal the regulatory aspects of ZP genes/proteins.

Normally, ZP thickness increases gradually during follicular development. The measurement of ZP thickness in the different genotypes of 3-mo-old mice shows that the ZP thickness is less in the FORKO mice in the preantral follicles but thicker in the secondary follicles compared with the wild-type mice. The thickness of secondary follicle ZP in FORKO mice might be related to the advanced development of "secondary" oocytes. From the present study, we cannot say whether the thinness of the ZP in our model simply reflects the different ratio of ZP-A, ZP-B, and ZP-C proteins or other unknown perturbations. Nevertheless, these data imply that infertility in the FORKO mice must also be related in part to changes in zona pellucida protein expression that will in turn influence the status of the entire follicle. However, it remains unclear where the initial molecular association of the three ZP proteins occurs—at the secretion level or gene level—and through what precise mechanism FSH-R signaling controls ZP protein expression. We conclude that reduced fertility and early reproductive senescence previously observed in haplo-insufficient females [23, 24] must also be a consequence of the loss of the delicate balance of intercellular communication.

In conclusion, our studies report for the first time that oocyte integrity and perhaps functional status are directly impaired in the absence of FSH-R signaling. Evidence emerging from haplo-insufficient mice also suggests the existence of a clear gene dose-related effect on the oocytes. These are related to alteration in many growth factor-related genes and structural glycoproteins produced by the oocytes. Thus, collectively, these data draw attention to the possible link between embryonic and/or immediate postnatal defects during FSH-R haplo-insufficiency that need to be explored in future investigations. We believe that these phenomena may have relevance to premature ovarian failure and lower reproductive success in middle-age women.


    ACKNOWLEDGMENTS
 
We thank Drs. U. Eberspaecher and S. Shimasaki for the kind gift of antibody reagents used in the study. We appreciate the help of Andrea Mogas and Shu Ren Zhang in management of the animals.


    FOOTNOTES
 
1 This work was supported by the Canadian Institute of Health Research and in part by a studentship to A.B. Back

2 Correspondence: M. Ram Sairam, Molecular Reproduction Research Laboratory, Clinical Research Institute of Montréal, 110, avenue des Pins West, Montréal, PQ, Canada H2W 1R7. FAX: 514 987 5585; sairamm{at}ircm.qc.ca Back

Received: 17 January 2003.

First decision: 22 February 2003.

Accepted: 15 May 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hirshfield AN, Midgley AR Jr. The role of FSH in the selection of large ovarian follicles in the rat. Biol Reprod 1978 19:606-611[Abstract]
  2. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000 21:200-214[Abstract/Free Full Text]
  3. Horie K, Takakura K, Taii S, Narimoto K, Noda Y, Nishikawa S, Nakayama H, Fujita J, Mori T. The expression of c-Kit protein during oogenesis and early embryonic development. Biol Reprod 1991 45:547-552[Abstract]
  4. Liang L, Soyal SM, Dean J. FIG{alpha}, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development 1997 124:4939-4947[Abstract]
  5. Soyal SM, Amleh A, Dean J. FIG{alpha}, a germ cell-specific transcription factor required for ovarian follicle formation. Development 2000 127:4645-4654[Abstract]
  6. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 1998 204:373-384[CrossRef][Medline]
  7. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 1999 13:1018-1034[Abstract/Free Full Text]
  8. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000 25:279-283[CrossRef][Medline]
  9. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 2001 276:11387-11392[Abstract/Free Full Text]
  10. Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci U S A 2002 99:8060-8065[Abstract/Free Full Text]
  11. Packer AI, Hsu YC, Besmer P, Bachvarova RF. The ligand of the c-Kit receptor promotes oocyte growth. Dev Biol 1994 161:194-205[CrossRef][Medline]
  12. Vanderhyden BC, Telfer EE, Eppig JJ. Mouse oocytes promote proliferation of granulosa cells from preantral and antral follicles in vitro. Biol Reprod 1992 46:1196-1204[Abstract]
  13. McGrath SA, Esquela AF, Lee SJ. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995 9:131-136[Abstract]
  14. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996 383:531-535[CrossRef][Medline]
  15. Bleil JD, Wassarman PM. Structure and function of the zona pellucida: identification and characterization of the proteins of the mouse oocyte's zona pellucida. Dev Biol 1980 76:185-202[CrossRef][Medline]
  16. Eppig JJ. Intercommunication between mammalian oocytes and companion somatic cells. Bioessays 1991 13:569-574[CrossRef][Medline]
  17. Ulloa-Aguirre A, Midgley AR Jr, Beitins IZ, Padmanabhan V. Follicle-stimulating isohormones: characterization and physiological relevance. Endocr Rev 1995 16:765-787[CrossRef][Medline]
  18. Patsoula E, Loutradis D, Drakakis P, Kallianidis K, Bletsa R, Michalas S. Expression of mRNA for the LH and FSH receptors in mouse oocytes and preimplantation embryos. Reproduction 2001 121:455-461[Abstract]
  19. Meduri G, Charnaux N, Driancourt MA, Combettes L, Granet P, Vannier B, Loosfelt H, Milgrom E. Follicle-stimulating hormone receptors in oocytes?. J Clin Endocrinol Metab 2002 87:2266-2276[Abstract/Free Full Text]
  20. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997 18:739-773[Abstract/Free Full Text]
  21. Babu PS, Krishnamurthy H, Chedrese PJ, Sairam MR. Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation. J Biol Chem 2000 275:27615-27626[Abstract/Free Full Text]
  22. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A 1998 95:13612-13617[Abstract/Free Full Text]
  23. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 2000 141:4295-4308[Abstract/Free Full Text]
  24. Danilovich N, Sairam MR. Haploinsufficiency of the follicle-stimulating hormone receptor accelerates oocyte loss inducing early reproductive senescence and biological aging in mice. Biol Reprod 2002 67:361-369[Abstract/Free Full Text]
  25. Danilovich N, Javeshghani D, Xing W, Sairam MR. Endocrine alterations and signaling changes associated with declining ovarian function and advanced biological aging in follicle-stimulating hormone receptor haploinsufficient mice. Biol Reprod 2002 67:370-378[Abstract/Free Full Text]
  26. Beckman M. Menopause mouse. Hormone-hampered rodents mimic menopause. Science's SAGE KE 14 August 2002; 32:112
  27. Balla A, Danilovich N, Yang Y, Sairam MR. Dynamics of ovarian development in the follitropin receptor knockout (FORKO) immature mouse: structural and functional implications for ovarian reserve. Biol Reprod 2003 69:1281-1293.[Abstract/Free Full Text]
  28. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991 337:1375-1377[CrossRef][Medline]
  29. Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2001 2:280-291[CrossRef][Medline]
  30. Eberspaecher U, Becker A, Bringmann P, van der ML, Donner P. Immunohistochemical localization of zona pellucida proteins ZPA, ZPB and ZPC in human, cynomolgus monkey and mouse ovaries. Cell Tissue Res 2001 303:277-287[CrossRef][Medline]
  31. Harris JD, Hibler DW, Fontenot GK, Hsu KT, Yurewicz EC, Sacco AG. Cloning and characterization of zona pellucida genes and cDNAs from a variety of mammalian species: the ZPA, ZPB and ZPC gene families. DNA Seq 1994 4:361-393[Medline]
  32. Odor DL, Blandau RJ. Ultrastructural studies on fetal and early postnatal mouse ovaries. I. Histogenesis and organogenesis. Am J Anat 1969 124:163-186[CrossRef][Medline]
  33. Wassarman PM, Mortillo S. Structure of the mouse egg extracellular coat, the zona pellucida. Int Rev Cytol 1991 130:85-110[Medline]
  34. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci U S A 2002 99:2890-2894[Abstract/Free Full Text]
  35. Erickson GF, Shimasaki S. The role of the oocyte in folliculogenesis. Trends Endocrinol Metab 2000 11:193-198[CrossRef][Medline]
  36. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996 17:121-155[CrossRef][Medline]
  37. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001 122:829-838[Abstract]
  38. Bousquet D, Leveille MC, Roberts KD, Chapdelaine A, Bleau G. The cellular origin of the zona pellucida antigen in the human and hamster. J Exp Zool 1981 215:215-218[CrossRef][Medline]
  39. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, Celeste AJ, Matzuk MM. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001 15:854-866[Abstract/Free Full Text]
  40. Galloway SM, Gregan SM, Wilson T, McNatty KP, Juengel JL, Ritvos O, Davis GH. Bmp15 mutations and ovarian function. Mol Cell Endocrinol 2002 191:15-18[CrossRef][Medline]
  41. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL. Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998 20:353-357[CrossRef][Medline]
  42. Wu JY, Gonzalez-Robayna IJ, Richards JS, Means AR. Female fertility is reduced in mice lacking Ca2+/calmodulin-dependent protein kinase IV. Endocrinology 2000 141:4777-4783[Abstract/Free Full Text]
  43. McMullen ML, Cho BN, Yates CJ, Mayo KE. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit. Endocrinology 2001 142:5005-5014[Abstract/Free Full Text]
  44. Rankin T, Talbot P, Lee E, Dean J. Abnormal zonae pellucidae in mice lacking ZP1 result in early embryonic loss. Development 1999 126:3847-3855[Abstract]
  45. Rankin TL, O'Brien M, Lee E, Wigglesworth K, Eppig J, Dean J. Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development. Development 2001 128:1119-1126[Abstract]
  46. Green DP. Three-dimensional structure of the zona pellucida. Rev Reprod 1997 2:147-156[Abstract]



This article has been cited by other articles:


Home page
FASEB J.Home page
S. A. Williams and P. Stanley
Mouse fertility is enhanced by oocyte-specific loss of core 1-derived O-glycans
FASEB J, July 1, 2008; 22(7): 2273 - 2284.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Tiwari-Pandey, Y. Yang, J. Aravindakshan, and M.R. Sairam
Normalization of hormonal imbalances, ovarian follicular dynamics and metabolic effects in follitrophin receptor knockout mice
Mol. Hum. Reprod., May 1, 2007; 13(5): 287 - 297.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Inzunza, A. Morani, G. Cheng, M. Warner, J. Hreinsson, J.-A. Gustafsson, and O. Hovatta
Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice
PNAS, January 9, 2007; 104(2): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
X. Gueripel, V. Brun, and A. Gougeon
Oocyte Bone Morphogenetic Protein 15, but not Growth Differentiation Factor 9, Is Increased During Gonadotropin-Induced Follicular Development in the Immature Mouse and Is Associated with Cumulus Oophorus Expansion
Biol Reprod, December 1, 2006; 75(6): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T R. Kumar
What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?
Reproduction, September 1, 2005; 130(3): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M Myers, K L Britt, N G M Wreford, F J P Ebling, and J B Kerr
Methods for quantifying follicular numbers within the mouse ovary
Reproduction, May 1, 2004; 127(5): 569 - 580.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Balla, N. Danilovich, Y. Yang, and M. R. Sairam
Dynamics of Ovarian Development in the FORKO Immature Mouse: Structural and Functional Implications for Ovarian Reserve
Biol Reprod, October 1, 2003; 69(4): 1281 - 1293.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/4/1294    most recent
biolreprod.103.015610v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Sairam, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation